Oragenics, Inc. (OGEN): Prakiraan wutah bathi kanggo taun ngarep

Oragenics, Inc. (OGEN) - logo korporat

Investing in Oragenics, Inc. (OGEN) entails high early-stage R&D risks and potential funding shortages. The target net income per share growth rate reflects current expert expectations, with the metric standing at 0.00. Oragenics, Inc. (OGEN) is developing innovative nasal vaccines in the US, leveraging unique delivery methods. The current strategy is based on test results for brain injury drugs and cost control through equity issuances.

OGEN - Proyeksi tambahing bathi saben saham ing taun ngarep oragenics.com ing rentang 04.07.2022 - 15.11.2026

Rincian metrik lan analitis perusahaan Oragenics Inc. (OGEN)

- rega saham lan konsensus proyeksi valuasi:
Rega saham oragenics.com|OGEN - Rata-rata rega prakiraan
- data kapitalisasi bursa:
Kapitalisasi pasar Oragenics|OGEN - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Oragenics|OGEN - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku oragenics.com|OGEN - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Oragenics, Inc.|OGEN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Oragenics|OGEN - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Oragenics, Inc.|OGEN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Oragenics|Likuiditas cepet oragenics.com
- statistik bathi lan rasio pasar:
OGEN - Bathi pungkasan|Proyeksi bathi mangsa ngarep Oragenics, Inc.|OGEN - Pangali P/E|Pangali Forward P/E Oragenics Inc.|OGEN - Rasio rega marang wutah bathi resik|Pangali EV/EBITDA Oragenics|OGEN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Oragenics|OGEN - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan oragenics.com|OGEN - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Oragenics, Inc.
- informasi babagan volume dodolan lan pendapatan:
OGEN - Dodolan perusahaan|Prakiraan pendapatan perusahaan Oragenics Inc.|OGEN - Koefisien rega marang pendapatan|Multiplikator forward rega marang pendapatan Oragenics|OGEN - Dinamika pendapatan YoY sajrone rolas wulan kepungkur
Analisis umum perusahaan:OGEN, oragenics.com
Barang utama Oragenics

This indicator measures the consensus earnings per share (EPS) growth forecast, reflecting market expectations regarding future profitability and the sustainability of the business model. Analyzing the estimated net EPS growth for the coming year allows for an assessment of how the diversification of Oragenics, Inc. (OGEN) developments in vaccines and concussion therapy mitigates fundamental risks and impacts the issuer's investment attractiveness.

Analisis pesaing

SMMT (Summit Therapeutics plc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Moderna, Inc. MRNA|Prakiraan wutah bathi kanggo taun ngarep PCVX|Prakiraan wutah bathi saben saham kanggo taun ngarep Tarsus Pharma TARS|CorMedix - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep MCRB (Seres)|sperotherapeutics.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep SCYNEXIS SCYX|an2therapeutics.com (ANTX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep PolyPid Limited (PYPD)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep YS Biopharma Co., Ltd.|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep ITRM (iterumtx.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BiomX Ltd (PHGE)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Soligenix Inc|60 Degrees Pharmaceuticals, Inc. (SXTP) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|OpGen Inc (OPGN) - Prakiraan wutah bathi resik saben saham ing taun ngarep